Search

Insulet Corp

Fechado

SetorSaúde

132.62 -20.36

Visão Geral

Variação de preço das ações

24h

Atual

Mín

164.35

Máximo

170.86

Indicadores-chave

By Trading Economics

Rendimento

-11M

91M

Vendas

-22M

762M

P/E

Médio do Setor

38.551

64.641

EPS

1.42

Margem de lucro

11.96

Funcionários

5,400

EBITDA

-23M

154M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+30.45% upside

Dividendos

By Acuity

Próximos Ganhos

5 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-442M

11B

Abertura anterior

152.98

Fecho anterior

132.62

Sentimento de Notícias

By Acuity

83%

17%

312 / 340 Ranking em Healthcare

Insulet Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de ago. de 2026, 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31 de jul. de 2026, 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29 de jul. de 2026, 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

28 de jul. de 2026, 19:06 UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

27 de jul. de 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24 de jul. de 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22 de jul. de 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20 de jul. de 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Comparação entre Pares

Variação de preço

Insulet Corp Previsão

Preço-alvo

By TipRanks

30.45% parte superior

Previsão para 12 meses

Média 221.38 USD  30.45%

Máximo 294 USD

Mínimo 172 USD

Com base em 22 analistas de Wall Street que oferecem metas de preço de 12 meses para Insulet Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

22 ratings

18

Comprar

3

Manter

1

Vender

Sentimento

By Acuity

312 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat